The short version of hGH fragment fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-05-01. Anything still debated is marked as such rather than presented as settled.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
| Property | Value | Notes |
|---|---|---|
| Common synonym | hGH fragment 176-191 | Refers to the C-terminal segment |
| Appearance | White to off-white powder | Typically supplied lyophilized |
| Solubility | Soluble in water and aqueous buffers | Confirm with technical data |
| Typical storage temperature | -20 °C for dry powder | Protect from moisture and light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Early interest in AOD-9604 centered on whether a fragment of human growth hormone could influence fat metabolism without the broader effects of the full hormone. Cell and animal studies reported changes in fat storage and breakdown. Human trials followed, but the results were not strong enough to secure regulatory approval. The compound remains available for laboratory research, and its clinical potential is still described as uncertain. Studies continue to examine its activity and safety profile.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Upon impact with the samples x-rays are emitted that can be used to identify the composition of the shell. X-ray diffraction is a method for determining eggshell composition that uses X-rays to directly bombard powdered eggshell. Upon impact some of the x-rays will be diffracted at different angles and intensities depending on the specific elements present in the eggshell. Allosterics In order to test out how allosterics played a part in dinosaur egg size, scientists used modern day animal species such as birds, crocodiles, and tortoises in their experiment. They set the bird group as representing the theropods with the reptiles representing the sauropod group. The laid eggs of each species where compared with one another over the course of the study as well as against the fossilized eggs. The results that was retrieved from the experiment was that while sauropods laid smaller eggs in greater amounts each year, dinosaur of the theropod group was revealed to lay larger eggs less frequently over the years, similar to modern birds today.
Clandestine atomic spies from the Soviet Union, who infiltrated the Manhattan Project during WWII, played a major role in increasing tensions that led to the Cold War. In addition to usual espionage, the Western agencies paid special attention to debriefing Eastern Bloc defectors. Edward Jay Epstein describes that the CIA understood that the KGB used "provocations", or fake defections, as a trick to embarrass Western intelligence and establish Soviet double agents. As a result, from 1959 to 1973, the CIA required that East Bloc defectors went through a counterintelligence investigation before being recruited as a source of intelligence. During the late 1970s and 1980s, the KGB perfected its use of espionage to sway and distort diplomacy. Active measures were "clandestine operations designed to further Soviet foreign policy goals," consisting of disinformation, forgeries, leaks to foreign media, and the channeling of aid to militant groups. Retired KGB Major General Oleg Kalugin described active measures as "the heart and soul of Soviet intelligence." During the Sino-Soviet split, "spy wars" also occurred between the USSR and PRC.
Barcodes – The barcode was invented in 1948. However, NASA developed a type of barcode label that could endure in space environments. Cordless power tools – The first cordless power tool was unveiled by Black & Decker in 1961. These were used by NASA and a number of spinoff products came out of those projects such as portable cordless vacuums. Magnetic resonance imaging (MRI), best known as a device for body scanning. NASA contractor JPL developed digital signal processing, which has applications in medical imaging used by MRIs. However, JPL works like a department of NASA. Microchip – The first hybrid integrated circuit was developed by Texas Instruments in 1958, and then the silicon integrated circuit microchip was invented by Robert Noyce at Fairchild Semiconductor in 1959. The impact of NASA was in creating a massive impetus for development in this area. Quartz clocks – The first quartz clock was invented in 1927. However, in the late 1960s, NASA partnered with a company to make a highly accurate quartz clock. Smoke detectors – NASA's connection to the modern smoke detector is that it developed one with adjustable sensitivity as part of the Skylab project; this development helps with nuisance tripping. Space Pen – An urban legend states that NASA spent a large amount of money to develop a pen that would write in space (the result purportedly being the Fisher Space Pen), while the Soviets used pencils. While NASA did spend funds to create a pen to work in space, the project was cancelled due to public opposition, and U.S.
In 1945 the Dutch royal family sent 100,000 tulip bulbs to Ottawa in gratitude for Canadians having sheltered the future Queen Juliana and her family for the preceding three years during the Nazi occupation of the Netherlands. In 1946 Juliana sent another 20,500 bulbs requesting that a display be created for the hospital, and promised to send 10,000 more bulbs each year. By 1963 the Canadian Tulip Festival featured more than 2 million tulips, rising to nearly 3 million by 1995. The Netherlands continues to send 20,000 bulbs to Canada each year (10,000 from the royal family and 10,000 from the Dutch Bulb Growers Association).
Sources: en.wikipedia.org
==== Types of diabetes mellitus ==== Between 1850 and 1875, French researchers Apollinaire Bouchardat and E. Lancereux acknowledged a need for classification. They distinguished between those diabetics that were lean, had severe symptoms, poor outcomes, and pancreatic lesions at autopsy (diabetes maigre), and those that were overweight, presented later in life with a milder form of the disease and had a better prognosis if put on a low-calorie diet (diabetes gras). These descriptions are comparable to the two types identified by Ayurvedic physicians Sushruta and Charaka (400–500 AD), with one type being associated with youth and the other with being overweight. Harold Percival Himsworth established a clearer distinction in 1936, differentiating two types of diabetes based on sensitivity to insulin (both injected and pancreatic). In 1950, R. D. Lawrence observed that some diabetics were deficient in insulin and that some were not. Philip Hugh-Jones, while working in Jamaica in 1955, clarified Lawrence's classification and coined the terms "type 1" and "type 2" diabetes. He also noted a rarer variety observed in insulin-resistant youth (whose condition could not be placed into the two types). He called this third group "type J", where J stood for Jamaica. The terms type 1 and 2 were for some time forgotten. In 1976, they were revived and popularized by Andrew Cudworth after he discovered the link between type 1 diabetes and a specific genetic marker.
Tyrosinase is an oxidase that is the rate-limiting enzyme for controlling the production of melanin. The enzyme is mainly involved in two distinct reactions of melanin synthesis otherwise known as the Raper–Mason pathway. Firstly, the hydroxylation of a monophenol and secondly, the conversion of an o-diphenol to the corresponding o-quinone. o-Quinone undergoes several reactions to eventually form melanin. Tyrosinase is a copper-containing enzyme present in plant and animal tissues that catalyzes the production of melanin and other pigments from tyrosine by oxidation. It is found inside melanosomes which are synthesized in the skin melanocytes. In humans, the tyrosinase enzyme is encoded by the TYR gene.
Trotsky's permanent revolution advocated rapid industrialisation, elimination of private farming and having the Soviet Union promote the spread of communist revolution abroad. Stalin's socialism in one country stressed moderation and development of positive relations between the Soviet Union and other countries to increase trade and foreign investment. To politically isolate and oust Trotsky from the party, Stalin expediently advocated socialism in one country, a policy to which he was indifferent. In 1925, the 14th Congress of the All-Union Communist Party (Bolsheviks) chose Stalin's policy, defeating Trotsky as a possible leader of the party and of the Soviet Union. In the 1925–1927 period, Stalin dissolved the troika and disowned the centrist Kamenev and Zinoviev for an expedient alliance with the three most prominent leaders of the so-called Right Opposition, namely Alexei Rykov (Premier of Russia, 1924–1929; Premier of the Soviet Union, 1924–1930), Nikolai Bukharin (General Secretary of the Comintern, 1926–1929; Editor-in-Chief of Pravda, 1918–1929), and Mikhail Tomsky (Chairman of the All-Russian Central Council of Trade Unions in the 1920s). In 1927, the party endorsed Stalin's policy of socialism in one country as the Soviet Union's national policy and expelled the leftist Trotsky and the centrists Kamenev and Zinoviev from the Politburo. In 1929, Stalin politically controlled the party and the Soviet Union by way of deception and administrative acumen.
Sources: en.wikipedia.org
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.
No. It is a shortened peptide fragment, not the full hormone. It does not contain the entire hGH sequence and is studied for different proposed effects.
Regulatory approvals for weight loss are not established in major jurisdictions. Some human trials reported modest changes, but the evidence is limited, and it remains a research compound.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.